In patients receiving percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI), post-conditioning therapy reduces infarct size and edema by one-third compared ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window ORLANDO -- ...
TRX®, the global leader in functional training, and BlazePod®, the pioneer of light-based reaction training, today announced ...
CAMBRIDGE, Mass. & MENLO PARK, Calif.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) and Forty Seven, Inc. (Nasdaq:FTSV) announced today that they have entered into a research collaboration to ...
Massachusetts biotech Sentien has filed for approval to start clinical trials of a blood filtering device packed with bone marrow cells for severe cases of acute kidney injury (AKI). It will be the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results